122 related articles for article (PubMed ID: 6982480)
21. Characterisation using microphysiometry of CRF receptor pharmacology.
Smart D; Coppell A; Rossant C; Hall M; McKnight AT
Eur J Pharmacol; 1999 Aug; 379(2-3):229-35. PubMed ID: 10497910
[TBL] [Abstract][Full Text] [Related]
22. Presence of corticotropin-releasing factor-stimulated adenylate cyclase activity in rat retina.
Olianas MC; Onali P
J Neurochem; 1990 Jun; 54(6):1967-71. PubMed ID: 2159980
[TBL] [Abstract][Full Text] [Related]
23. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
24. The fish neuropeptide urotensin I: its physiology and pharmacology.
Lederis K; Fryer JN; Yulis CR
Peptides; 1985; 6 Suppl 3():353-61. PubMed ID: 3008124
[TBL] [Abstract][Full Text] [Related]
25. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide.
Baigent SM; Lowry PJ
J Mol Endocrinol; 2000 Feb; 24(1):53-63. PubMed ID: 10656997
[TBL] [Abstract][Full Text] [Related]
26. Presence of sauvagine-like epitopes in the interrenal gland of the bullfrog Rana catesbeiana.
Gonzalez GC; Bountzioukas S; Lederis K; Lukowiak K
Cell Tissue Res; 1996 Jan; 283(1):117-23. PubMed ID: 8581951
[TBL] [Abstract][Full Text] [Related]
27. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
Heldwein KA; Redick DL; Rittenberg MB; Claycomb WC; Stenzel-Poore MP
Endocrinology; 1996 Sep; 137(9):3631-9. PubMed ID: 8756527
[TBL] [Abstract][Full Text] [Related]
28. Peptides of the corticoliberin superfamily attenuate thermal and neurogenic inflammation in rat pawskin.
Wei ET; Kiang JG
Eur J Pharmacol; 1989 Sep; 168(1):81-6. PubMed ID: 2583234
[TBL] [Abstract][Full Text] [Related]
29. Use of selective mesenteric dilator peptides to examine the role of the intestine in experimental hemorrhagic shock.
MacCannell KL; Newton CA
Circ Shock; 1985; 17(3):195-203. PubMed ID: 4075506
[TBL] [Abstract][Full Text] [Related]
30. CRF, urotensin I, and sauvagine stimulate the release of POMC-derived peptides from goldfish neurointermediate lobe cells.
Tran TN; Fryer JN; Lederis K; Vaudry H
Gen Comp Endocrinol; 1990 Jun; 78(3):351-60. PubMed ID: 2161377
[TBL] [Abstract][Full Text] [Related]
31. Isolation, analysis of structure, synthesis, and biological actions of urotensin I neuropeptides.
Lederis K; Letter A; McMaster D; Ichikawa T; MacCannell KL; Kobayashi Y; Rivier J; Rivier C; Vale W; Fryer J
Can J Biochem Cell Biol; 1983 Jul; 61(7):602-14. PubMed ID: 6313156
[TBL] [Abstract][Full Text] [Related]
32. Regulation of MSH release from the neurointermediate lobe of Xenopus laevis by CRF-like peptides.
Verburg-Van Kemenade BM; Jenks BG; Cruijsen PM; Dings A; Tonon MC; Vaudry H
Peptides; 1987; 8(6):1093-100. PubMed ID: 2831518
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity.
Dautzenberg FM; Huber G; Higelin J; Py-Lang G; Kilpatrick GJ
Neuropharmacology; 2000 Jun; 39(8):1368-76. PubMed ID: 10818253
[TBL] [Abstract][Full Text] [Related]
34. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstrictor responses by a vasodilator peptide, urotensin I: comparison with nifedipine.
Bolt GR; Itoh H; Lederis K; MacCannell KL
J Pharmacol Exp Ther; 1989 Dec; 251(3):1147-54. PubMed ID: 2574741
[TBL] [Abstract][Full Text] [Related]
35. Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.
Barker DM; Corder R
Br J Pharmacol; 1999 Jan; 126(1):317-25. PubMed ID: 10051151
[TBL] [Abstract][Full Text] [Related]
36. Effects of corticotropin releasing factor and sauvagine on social behavior of isolated mice.
Mele A; Cabib S; Oliverio A; Melchiorri P; Puglisi-Allegra S
Peptides; 1987; 8(5):935-8. PubMed ID: 3501578
[TBL] [Abstract][Full Text] [Related]
37. Sauvagine: effects on thermoregulation in the rat.
Broccardo M
Pharmacol Res; 1990; 22(2):189-96. PubMed ID: 2330343
[TBL] [Abstract][Full Text] [Related]
38. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands.
Krause K; Schnitger A; Fimmel S; Glass E; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):166-70. PubMed ID: 17326013
[TBL] [Abstract][Full Text] [Related]
39. Direct regulation of GnRH transcription by CRF-like peptides in an immortalized neuronal cell line.
Tellam DJ; Perone MJ; Dunn IC; Radovick S; Brennand J; Rivier JE; Castro MG; Lovejoy DA
Neuroreport; 1998 Oct; 9(14):3135-40. PubMed ID: 9831440
[TBL] [Abstract][Full Text] [Related]
40. Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats.
Gardiner SM; March JE; Kemp PA; Davenport AP; Bennett T
Br J Pharmacol; 2001 Apr; 132(8):1625-9. PubMed ID: 11309232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
